- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tscan Therapeutics Inc (TCRX)
Assess today's live Tscan Therapeutics Inc (TCRX) share price, performance and insights using our live NASDAQ: TCRX stock exchange data.
Analyse the historical data and Tscan Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Tscan Therapeutics share price buy/sell indicators using real-time data (or discuss the Tscan Therapeutics (TCRX) stock price today with other investors in the Tscan Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ TCRX share price (ISIN: US89854M1018) to enhance your trading decisions with our free investment tools and resources.
What Is the Tscan Therapeutics Inc Share Price Today?
The Tscan Therapeutics share price today is 0.91.
What Is the Stock Symbol for Tscan Therapeutics Inc
The stock symbol (or 'ticker') for Tscan Therapeutics Inc is "TCRX."
What Stock Exchange Does Tscan Therapeutics Inc Trade On?
Tscan Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Tscan Therapeutics Inc a Good Stock to Buy?
Determining whether Tscan Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Tscan Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Tscan Therapeutics share price buy/sell indicators using real-time data (or discuss the Tscan Therapeutics (TCRX) stock price today with other investors in the Tscan Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ TCRX share price (ISIN: US89854M1018) to enhance your trading decisions with our free investment tools and resources.
What Is the Tscan Therapeutics Inc Share Price Today?
The Tscan Therapeutics share price today is 0.91.
What Is the Stock Symbol for Tscan Therapeutics Inc
The stock symbol (or 'ticker') for Tscan Therapeutics Inc is "TCRX."
What Stock Exchange Does Tscan Therapeutics Inc Trade On?
Tscan Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Tscan Therapeutics Inc a Good Stock to Buy?
Determining whether Tscan Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.90
0.93
52 wk Range
0.88
3.43
Unusual Post-Market activity
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.900.93
52 wk Range
0.883.43
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TCRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
6.00
Upside
+559.34%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Tscan Therapeutics Company Profile
TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company’s lead product candidates include TSC-100 and TSC-101 for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell transplantation (HCT) is in Phase I clinical trial, as well as eliminates residual disease and promotes donor chimerism. It also advanced TS-102 into IND-enabling activities. In addition, the company develops TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204, which are in Phase 1 clinical trial, for the treatment of solid tumors. It has collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to discover and develop novel TCR-T therapies; and Amgen Inc. to identify antigens recognized by T cells in patients with Crohn’s disease using TargetScan, a proprietary target discovery platform. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
Compare TCRX to Peers and Sector
Metrics to compare | TCRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTCRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −3.4x | −0.6x | |
PEG Ratio | 0.02 | 0.12 | 0.00 | |
Price/Book | 0.4x | 2.1x | 2.6x | |
Price / LTM Sales | 6.1x | 12.4x | 3.2x | |
Upside (Analyst Target) | - | 357.8% | 41.8% | |
Fair Value Upside | Unlock | 13.7% | 5.1% | Unlock |
Analyst Ratings
5 Buy
2 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 6.00
(+559.34% Upside)
Earnings
Latest Release
Nov 12, 2025
EPS / Forecast
-0.28 / -0.34
Revenue / Forecast
2.51M / 1.31M
People Also Watch
FAQ
What Is the Tscan Therapeutics (TCRX) Share Price Today?
The live Tscan Therapeutics share price today is 0.91
What Stock Exchange Does Tscan Therapeutics (TCRX) Trade On?
Tscan Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Tscan Therapeutics?
The stock symbol (also called a 'ticker') for Tscan Therapeutics is "TCRX."
What Is the Current Tscan Therapeutics Market Cap?
As of today, Tscan Therapeutics market capitalisation is 51.68M.
What Is Tscan Therapeutics's (TCRX) Earnings Per Share (TTM)?
The Tscan Therapeutics EPS is currently -2.51 (Trailing Twelve Months).
When Is the Next Tscan Therapeutics Earnings Date?
Tscan Therapeutics's next earnings report will be released on 11 Mar 2026.
Is TCRX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Tscan Therapeutics moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Tscan Therapeutics Stock Split?
Tscan Therapeutics has split 0 times. (See the TCRX stock split history page for full effective split date and price information.)
How Many Employees Does Tscan Therapeutics Have?
Tscan Therapeutics has 147 employees.
What is the current trading status of Tscan Therapeutics (TCRX)?
As of 24 Dec 2025, Tscan Therapeutics (TCRX) is trading at a price of 0.91, with a previous close of 0.90. The stock has fluctuated within a day range of 0.90 to 0.93, while its 52-week range spans from 0.88 to 3.43.
What Is Tscan Therapeutics (TCRX) Price Target According to Analysts?
The average 12-month price target for Tscan Therapeutics is USD6, with a high estimate of USD7 and a low estimate of USD5. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +559.34% Upside potential.
What Is the TCRX After Hours Price?
TCRX's last after hours stock price is 0.96, the stock has decreased by 0.04, or 4.40%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.